221 related articles for article (PubMed ID: 18023142)
1. Nitric oxide mediates the survival action of IGF-1 and insulin in pancreatic beta cells.
Cahuana GM; Tejedo JR; Hmadcha A; Ramírez R; Cuesta AL; Soria B; Martin F; Bedoya FJ
Cell Signal; 2008 Feb; 20(2):301-10. PubMed ID: 18023142
[TBL] [Abstract][Full Text] [Related]
2. nitric oxide triggers the phosphatidylinositol 3-kinase/Akt survival pathway in insulin-producing RINm5F cells by arousing Src to activate insulin receptor substrate-1.
Tejedo JR; Cahuana GM; Ramírez R; Esbert M; Jiménez J; Sobrino F; Bedoya FJ
Endocrinology; 2004 May; 145(5):2319-27. PubMed ID: 14764634
[TBL] [Abstract][Full Text] [Related]
3. Increased IRS-2 content and activation of IGF-I pathway contribute to enhance beta-cell mass in fetuses from undernourished pregnant rats.
Fernández E; Martín MA; Fajardo S; Escrivá F; Alvarez C
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E187-95. PubMed ID: 16912057
[TBL] [Abstract][Full Text] [Related]
4. Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function.
Granata R; Settanni F; Gallo D; Trovato L; Biancone L; Cantaluppi V; Nano R; Annunziata M; Campiglia P; Arnoletti E; Ghè C; Volante M; Papotti M; Muccioli G; Ghigo E
Diabetes; 2008 Apr; 57(4):967-79. PubMed ID: 18162507
[TBL] [Abstract][Full Text] [Related]
5. Hyperinsulinaemia increases the gene expression of endothelial nitric oxide synthase and the phosphatidylinositol 3-kinase/Akt pathway in rat aorta.
Toba H; Gomyo E; Miki S; Shimizu T; Yoshimura A; Inoue R; Sawai N; Tsukamoto R; Asayama J; Kobara M; Nakata T
Clin Exp Pharmacol Physiol; 2006; 33(5-6):440-7. PubMed ID: 16700876
[TBL] [Abstract][Full Text] [Related]
6. Interactive effects of insulin-like growth factor-1 and beta-estradiol on endothelial nitric oxide synthase activity in rat aortic endothelial cells.
Isenovic ER; Divald A; Milivojevic N; Grgurevic T; Fisher SE; Sowers JR
Metabolism; 2003 Apr; 52(4):482-7. PubMed ID: 12701063
[TBL] [Abstract][Full Text] [Related]
7. The insulin-like growth factor I receptor is required for Akt activation and suppression of anoikis in cells transformed by the ETV6-NTRK3 chimeric tyrosine kinase.
Martin MJ; Melnyk N; Pollard M; Bowden M; Leong H; Podor TJ; Gleave M; Sorensen PH
Mol Cell Biol; 2006 Mar; 26(5):1754-69. PubMed ID: 16478996
[TBL] [Abstract][Full Text] [Related]
8. IGF-1 protects oligodendrocyte progenitors against TNFalpha-induced damage by activation of PI3K/Akt and interruption of the mitochondrial apoptotic pathway.
Pang Y; Zheng B; Fan LW; Rhodes PG; Cai Z
Glia; 2007 Aug; 55(11):1099-107. PubMed ID: 17577243
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways.
Wente W; Efanov AM; Brenner M; Kharitonenkov A; Köster A; Sandusky GE; Sewing S; Treinies I; Zitzer H; Gromada J
Diabetes; 2006 Sep; 55(9):2470-8. PubMed ID: 16936195
[TBL] [Abstract][Full Text] [Related]
10. Insulin receptor substrate-4 signaling in quiescent rat hepatocytes and in regenerating rat liver.
Escribano O; Fernández-Moreno MD; Zueco JA; Menor C; Fueyo J; Ropero RM; Diaz-Laviada I; Román ID; Guijarro LG
Hepatology; 2003 Jun; 37(6):1461-9. PubMed ID: 12774026
[TBL] [Abstract][Full Text] [Related]
11. IRS-3 mediates insulin-induced glucose uptake in differentiated IRS-2(-/-) brown adipocytes.
Escribano O; Arribas M; Valverde AM; Benito M
Mol Cell Endocrinol; 2007 Mar; 268(1-2):1-9. PubMed ID: 17316975
[TBL] [Abstract][Full Text] [Related]
12. Dual regulation of upstream binding factor 1 levels by IRS-1 and ERKs in IGF-1-receptor signaling.
Sun H; Tu X; Liu M; Baserga R
J Cell Physiol; 2007 Sep; 212(3):780-6. PubMed ID: 17443674
[TBL] [Abstract][Full Text] [Related]
13. IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways.
Bibollet-Bahena O; Almazan G
J Neurochem; 2009 Jun; 109(5):1440-51. PubMed ID: 19453943
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of the Shb SH2 domain-protein in insulin-producing cells leads to altered signaling through the IRS-1 and IRS-2 proteins.
Welsh N; Makeeva N; Welsh M
Mol Med; 2002 Nov; 8(11):695-704. PubMed ID: 12520086
[TBL] [Abstract][Full Text] [Related]
15. Role of insulin receptor substrate-4 in IGF-I-stimulated HEPG2 proliferation.
Cuevas EP; Escribano O; Chiloeches A; Ramirez Rubio S; Román ID; Fernández-Moreno MD; Guijarro LG
J Hepatol; 2007 Jun; 46(6):1089-98. PubMed ID: 17408801
[TBL] [Abstract][Full Text] [Related]
16. Inducible nitric oxide synthase-nitric oxide plays an important role in acute and severe hypoxic injury to pancreatic beta cells.
Ko SH; Ryu GR; Kim S; Ahn YB; Yoon KH; Kaneto H; Ha H; Kim YS; Song KH
Transplantation; 2008 Feb; 85(3):323-30. PubMed ID: 18301327
[TBL] [Abstract][Full Text] [Related]
17. Resistin impairs insulin-evoked vasodilation.
Gentile MT; Vecchione C; Marino G; Aretini A; Di Pardo A; Antenucci G; Maffei A; Cifelli G; Iorio L; Landolfi A; Frati G; Lembo G
Diabetes; 2008 Mar; 57(3):577-83. PubMed ID: 18065520
[TBL] [Abstract][Full Text] [Related]
18. IGF-I prevents glutamate-induced motor neuron programmed cell death.
Vincent AM; Mobley BC; Hiller A; Feldman EL
Neurobiol Dis; 2004 Jul; 16(2):407-16. PubMed ID: 15193297
[TBL] [Abstract][Full Text] [Related]
19. Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.
Ibrahim YH; Byron SA; Cui X; Lee AV; Yee D
Mol Cancer Res; 2008 Sep; 6(9):1491-8. PubMed ID: 18819936
[TBL] [Abstract][Full Text] [Related]
20. Chronic inhibition of mammalian target of rapamycin signaling downregulates insulin receptor substrates 1 and 2 and AKT activation: A crossroad between cancer and diabetes?
Di Paolo S; Teutonico A; Leogrande D; Capobianco C; Schena PF
J Am Soc Nephrol; 2006 Aug; 17(8):2236-44. PubMed ID: 16807405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
